Drate Tablets 70Mg

Product Overview

Product Form: Tablets
Pack Size: 70mg
Manufactured By: SJ & G Fazal Elahi
Prescription Required: Yes

Product Details

Drate Tablets 70mg are formulated with Alendronate Sodium, a medication used primarily to manage and treat osteoporosis. This medication works by localizing to bone resorption sites and inhibiting osteoclast activity, which helps slow down the loss of bone density. Regular use of Tablets is essential for effective treatment, as the active ingredient is incorporated into the bone matrix and continuously suppresses bone degradation.

Purposes

The main purpose of Drate Tablets 70mg is to treat osteoporosis in postmenopausal women, reduce the risk of fractures (including those in the hip and spine), and manage osteoporosis in men. It is also prescribed for the treatment and prevention of glucocorticoid-induced osteoporosis in both men and women, as well as for Paget's disease of the bone.

Warnings

• Warning 1: Consider other causes of osteoporosis beyond aging, estrogen deficiency, and glucocorticoid use when treating patients.
• Warning 2: Physicians should monitor for esophageal reactions, such as difficulty swallowing, chest pain, or worsening heartburn, and discontinue the use of Drate Tablets 70mg if these symptoms appear.
• Warning 3: This medication is not recommended for patients with severe renal insufficiency, as it may lead to complications.

Adverse Effects

Common side effects of Tablets include hypersensitivity reactions like rash, myalgia, or malaise. Gastrointestinal issues such as esophagitis, ulcers, or esophageal erosions are possible, along with rare occurrences of severe skin reactions like Stevens-Johnson syndrome. Other side effects may include hypocalcemia and ocular conditions like uveitis or scleritis.

Cautions

Patients using Tablets should ensure adequate intake of calcium and vitamin D to prevent small decreases in serum calcium and phosphate levels. Care must be taken in patients with esophageal abnormalities or those unable to remain upright for 30 minutes post-administration. Discontinue use immediately if esophageal or severe gastrointestinal symptoms arise.